Syros Pharmaceuticals (SYRS) IPO Pushes Higher Into the Close
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts SYRS Hot Sheet
Join SI Premium – FREE
Today's IPO for Syros Pharmaceuticals (NASDAQ: SYRS) is pressing higher into the close. Shares last traded up 46.8% to $18.35 after pricing at $12.50 and opening at $15 earlier today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic may not secure investment-grade rating after IPO, Blackstone tells investors - FT
- Aspen Neuroscience prices IPO at $15 per share on Nasdaq
- Trump: Looking At Whether Binance Hack Is By North Korea - Bloomberg
Create E-mail Alert Related Categories
Hot IPOs, IPOs, Momentum Movers, Trader TalkRelated Entities
IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
